{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:39:45Z","timestamp":1768077585176,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.transci.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T13:06:42Z","timestamp":1418994402000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"52","author":[{"given":"Jui-Hsiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Hua","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Chung","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Tseng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2014.12.005_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","article-title":"Guillain-Barre syndrome (GBS)","volume":"62","author":"Pithadia","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.transci.2014.12.005_bib0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2014.12.005_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barre syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"Suppl. 1","key":"10.1016\/j.transci.2014.12.005_bib0025","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/s10072-006-0548-4","article-title":"Guillain-Barre syndrome","volume":"27","author":"Cosi","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.transci.2014.12.005_bib0030","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barre syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2014.12.005_bib0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1474-4422(06)70603-2","article-title":"Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre syndrome: a prospective study","volume":"5","author":"Durand","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2014.12.005_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.2010.01366.x","article-title":"Clinico-electrophysiological findings and prognosis of Guillain-Barre syndrome \u2013 10 years\u2019 experience","volume":"123","author":"Soysal","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.transci.2014.12.005_bib0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-981686","article-title":"Clinical presentation and course of childhood Guillain-Barre syndrome: a prospective multicentre study","volume":"38","author":"Korinthenberg","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.transci.2014.12.005_bib0050","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.transci.2014.12.005_bib0055","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2014.12.005_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2014.12.005_bib0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2014.12.005_bib0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: core curriculum 2008","volume":"52","author":"Kaplan","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2014.12.005_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-510X(98)00067-7","article-title":"Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption","volume":"157","author":"Tagawa","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.transci.2014.12.005_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5603\/AIT.2013.0002","article-title":"Complications in patients treated with plasmapheresis in the intensive care unit","volume":"45","author":"Szczeklik","year":"2013","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.transci.2014.12.005_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1526-0968.2002.00382.x","article-title":"Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barre syndrome","volume":"6","author":"Lyu","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.2920090102","article-title":"Complications of therapeutic plasma exchange: a recent assessment","volume":"9","author":"Couriel","year":"1994","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1526-0968.2004.00138.x","article-title":"Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barre syndrome","volume":"8","author":"Okamiya","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2014.12.005_bib0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<126::AID-JCA4>3.0.CO;2-W","article-title":"Experience of double filtration plasmapheresis in the treatment of Guillain-Barre syndrome","volume":"14","author":"Chen","year":"1999","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2014.12.005_bib0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.transci.2014.12.005_bib0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.transproceed.2011.03.025","article-title":"Plasmapheresis therapy in renal transplant patients: five-year experience","volume":"43","author":"Gungor","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transci.2014.12.005_bib0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2014.12.005_bib0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2014.12.005_bib0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2014.12.005_bib0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1468-1331.2003.00683.x","article-title":"Guillain-Barre syndrome in southern Taiwan: clinical features, prognostic factors and therapeutic outcomes","volume":"10","author":"Cheng","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.transci.2014.12.005_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-13-95","article-title":"Guillain-Barre Syndrome: natural history and prognostic factors: a retrospective review of 106 cases","volume":"13","author":"Gonzalez-Suarez","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.transci.2014.12.005_bib0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jca.10066","article-title":"Long-term prognosis for Guillain-Barre syndrome: evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis","volume":"18","author":"Cheng","year":"2003","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0155","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.lpm.2013.02.328","article-title":"Diagnosis, treatment and prognosis of Guillain-Barre syndrome (GBS)","volume":"42","author":"van Doorn","year":"2013","journal-title":"Press Med"},{"key":"10.1016\/j.transci.2014.12.005_bib0160","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","article-title":"Guillain-Barre syndrome: a prospective, population-based incidence and outcome survey","volume":"60","author":"Chio","year":"2003","journal-title":"Neurology"},{"issue":"Pt 10","key":"10.1016\/j.transci.2014.12.005_bib0165","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","article-title":"Haemophilus influenzae infection and Guillain-Barre syndrome","volume":"123","author":"Mori","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.transci.2014.12.005_bib0170","first-page":"923602","article-title":"Severe hyponatremia as the initial sign preceding Guillain-Barre syndrome, an acute inflammatory demyelinating polyneuropathy: a case report","volume":"2013","author":"Kloesel","year":"2013","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.transci.2014.12.005_bib0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.0b013e31820d8b40","article-title":"Guillain-Barre syndrome and SIADH","volume":"76","author":"Saifudheen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2014.12.005_bib0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1445-5994.2002.00322.x","article-title":"Guillain-Barre syndrome and hyponatraemia","volume":"33","author":"Colls","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.transci.2014.12.005_bib0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jca.1024","article-title":"Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures","volume":"16","author":"Kiprov","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2014.12.005_bib0190","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","article-title":"Therapeutic plasma exchange: complications and management","volume":"23","author":"Mokrzycki","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2014.12.005_bib0195","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1537-2995.2000.40080896.x","article-title":"Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome","volume":"40","author":"Rizvi","year":"2000","journal-title":"Transfusion"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050214002432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:57:17Z","timestamp":1537999037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050214002432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1473050214002432"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.005","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain\u2013Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}